{"transactions":[{"id":695530,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-05T20:03:45.000Z","date":"2026-08-04","kind":"sale","planned":false,"acquired":false,"shares":38800,"price":2.4589,"value":95405.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 75,000 shares of Common Stock underlying RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $2.415 to $2.540 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":589355,"source":{"system":"sec-edgar","filing":"0001193125-26-335019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526335019/ownership.xml","form_type":"4"}},{"id":767795,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-21T20:02:44.000Z","date":"2026-05-20","kind":"sale","planned":false,"acquired":false,"shares":25590,"price":1.879,"value":48083.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 50,000 shares of Common Stock underlying performance-based RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.835 to $1.935 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":628155,"source":{"system":"sec-edgar","filing":"0001193125-26-234390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526234390/ownership.xml","form_type":"4"}},{"id":788439,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T20:00:36.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":false,"shares":44444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":355556,"derivative":{"exercise_price":1.05,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":44444},"source":{"system":"sec-edgar","filing":"0001193125-26-211820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526211820/ownership.xml","form_type":"4"}},{"id":788438,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T20:00:36.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":false,"shares":122220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2025, such that all of the shares shall be fully vested and exercisable on January 1, 2028, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":152780,"derivative":{"exercise_price":1.32,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":122220},"source":{"system":"sec-edgar","filing":"0001193125-26-211820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526211820/ownership.xml","form_type":"4"}},{"id":788437,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-07T20:00:36.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":true,"shares":44444,"price":1.05,"value":46666.2,"ownership":{"direct":true},"balance_after":653745,"source":{"system":"sec-edgar","filing":"0001193125-26-211820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526211820/ownership.xml","form_type":"4"}},{"id":788436,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-07T20:00:36.000Z","date":"2026-05-06","kind":"exercise","planned":false,"acquired":true,"shares":122220,"price":1.32,"value":161330.4,"ownership":{"direct":true},"balance_after":609301,"source":{"system":"sec-edgar","filing":"0001193125-26-211820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526211820/ownership.xml","form_type":"4"}},{"id":937108,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-16T21:03:32.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.05,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001193125-26-015328","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526015328/ownership.xml","form_type":"4"}},{"id":937107,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-16T21:03:32.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vest with respect to 1/4th of the RSUs on each of January 8, 2027, January 8, 2028, January 8, 2029 and January 8, 2030, subject to the Reporting Person's continued service with the Issuer as of each such vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement."}],"balance_after":487081,"source":{"system":"sec-edgar","filing":"0001193125-26-015328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526015328/ownership.xml","form_type":"4"}},{"id":940908,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-12T21:04:22.000Z","date":"2026-01-09","kind":"sale","planned":false,"acquired":false,"shares":10589,"price":1.0648,"value":11275.1672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 17,500 shares of Common Stock underlying RSUs granted to the Reporting Person on January 15, 2025 and 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.05 to $1.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":387081,"source":{"system":"sec-edgar","filing":"0001193125-26-010356","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526010356/ownership.xml","form_type":"4"}},{"id":1074396,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-05T20:03:43.000Z","date":"2025-08-04","kind":"sale","planned":false,"acquired":false,"shares":9037,"price":1.0593,"value":9572.8941,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25,000 shares of Common Stock underlying RSUs granted to the Reporting Person on July 29, 2024. These sales were automatically executed pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell-to-cover\" transactions and were not made at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.045 to $1.075 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":397670,"source":{"system":"sec-edgar","filing":"0000950170-25-102983","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025102983/ownership.xml","form_type":"4"}},{"id":1301422,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-16T23:32:36.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2025, such that all of the shares shall be fully vested and exercisable on January 1, 2028, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":275000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000950170-25-006311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025006311/ownership.xml","form_type":"4"}},{"id":1301421,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-16T23:32:36.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2026, January 8, 2027, January 8, 2028 and January 8, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":406707,"source":{"system":"sec-edgar","filing":"0000950170-25-006311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025006311/ownership.xml","form_type":"4"}},{"id":1304261,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-13T21:05:23.000Z","date":"2025-01-10","kind":"sale","planned":false,"acquired":false,"shares":5654,"price":1.55,"value":8763.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 4,504 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,325 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $1.53 to $1.62 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":336707,"source":{"system":"sec-edgar","filing":"0000950170-25-004823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017025004823/ownership.xml","form_type":"4"}},{"id":1445226,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2024-07-31T22:00:56.000Z","date":"2024-07-29","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were granted pursuant to a restricted stock unit award.  100,000 of the units are subject to time-based vesting and 100,000 of the units are subject to performance-based vesting.  25,000 time-based units will vest on August 1, 2025 and 75,000 time-based units will vest on August 1, 2026, so long as the reporting person continues to serve as an employee of the issuer through each vesting date. Subject to the achievement of specified late-stage clinical and regulatory milestones of the issuer on or before July 29, 2028, half of the performance-based units will vest one year after the achievement of two of three of the milestones, and the remaining 50,000 of the performance-based units will vest on the date one year after the achievement of all three of the milestones, in each case subject to the grantee's continued employment with the issuer through each such vesting date."}],"balance_after":342361,"source":{"system":"sec-edgar","filing":"0000950170-24-088769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024088769/ownership.xml","form_type":"4"}},{"id":1661469,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T21:10:17.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2024, such that all of the shares shall be fully vested and exercisable on January 1, 2027, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":425000,"derivative":{"exercise_price":6.76,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0000950170-24-010490","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024010490/ownership.xml","form_type":"4"}},{"id":1681526,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2024-01-10T21:30:36.000Z","date":"2024-01-09","kind":"sale","planned":false,"acquired":false,"shares":10874,"price":4.37,"value":47519.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,326 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $4.02 to $4.50 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":142361,"source":{"system":"sec-edgar","filing":"0000950170-24-003652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024003652/ownership.xml","form_type":"4"}},{"id":1743776,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2023-11-13T21:01:53.000Z","date":"2023-11-09","kind":"sale","planned":true,"acquired":false,"shares":24363,"price":2.4,"value":58471.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023."}],"balance_after":153235,"source":{"system":"sec-edgar","filing":"0001209191-23-054968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123054968/doc4.xml","form_type":"4"}},{"id":2028299,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-07T21:18:21.000Z","date":"2023-02-06","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":425000,"derivative":{"exercise_price":6.77,"expiration_date":"2033-02-05","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001209191-23-007509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123007509/doc4.xml","form_type":"4"}},{"id":2056412,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2023-01-11T21:08:03.000Z","date":"2023-01-10","kind":"sale","acquired":false,"shares":11553,"price":5.24,"value":60537.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the Reporting Person on January 8, 2020, 4,503 shares of Common Stock underlying RSUs granted to the Reporting Person on January 20, 2021, and 8,325 shares of Common Stock underlying RSUs granted to the Reporting Person on January 25, 2022. These sales were made pursuant to an irrevocable election by the Reporting Person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $5.12 to $5.36 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in this footnote."}],"balance_after":177598,"source":{"system":"sec-edgar","filing":"0001209191-23-002977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123002977/doc4.xml","form_type":"4"}},{"id":2247352,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-02T20:04:14.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":54210,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-033481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122033481/doc4.xml","form_type":"4"}},{"id":2247351,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-06-02T20:04:14.000Z","date":"2022-06-01","kind":"sale","acquired":false,"shares":25000,"price":22.96,"value":574000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":189151,"source":{"system":"sec-edgar","filing":"0001209191-22-033481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122033481/doc4.xml","form_type":"4"}},{"id":2247350,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-06-02T20:04:14.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":25000,"price":6.55,"value":163750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":214151,"source":{"system":"sec-edgar","filing":"0001209191-22-033481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122033481/doc4.xml","form_type":"4"}},{"id":2307948,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T21:01:08.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":5567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":79210,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":5567},"source":{"system":"sec-edgar","filing":"0001209191-22-022495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122022495/doc4.xml","form_type":"4"}},{"id":2307947,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T21:01:08.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":19433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested."}],"balance_after":8195,"derivative":{"exercise_price":4.84,"expiration_date":"2025-01-05","underlying":"Common Stock","underlying_shares":19433},"source":{"system":"sec-edgar","filing":"0001209191-22-022495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122022495/doc4.xml","form_type":"4"}},{"id":2307946,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-04-04T21:01:08.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":25000,"price":38.85,"value":971250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":189151,"source":{"system":"sec-edgar","filing":"0001209191-22-022495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122022495/doc4.xml","form_type":"4"}},{"id":2307945,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-04-04T21:01:08.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":5567,"price":6.55,"value":36463.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":214151,"source":{"system":"sec-edgar","filing":"0001209191-22-022495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122022495/doc4.xml","form_type":"4"}},{"id":2307944,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-04-04T21:01:08.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":19433,"price":4.84,"value":94055.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":208584,"source":{"system":"sec-edgar","filing":"0001209191-22-022495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122022495/doc4.xml","form_type":"4"}},{"id":2423940,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T21:06:06.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":53058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in 48 equal month installments beginning on February 1, 2022 such that this option will be fully exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":53058,"derivative":{"exercise_price":39.87,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":53058},"source":{"system":"sec-edgar","filing":"0000899243-22-003424","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322003424/doc4.xml","form_type":"4"}},{"id":2423939,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-27T21:06:06.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":33302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of January 8, 2023, January 8, 2024, January 8, 2025 and January 8, 2026, subject to the Reporting Person's continued service with the Issuer as of each such date."}],"balance_after":189151,"source":{"system":"sec-edgar","filing":"0000899243-22-003424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322003424/doc4.xml","form_type":"4"}},{"id":2423958,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-27T21:04:55.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":15383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option will be fully exercisable on January 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Corrected ending balance of shares underlying this option as of July 1, 2021."}],"balance_after":184777,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":15383},"source":{"system":"sec-edgar","filing":"0000899243-22-003421","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924322003421/doc4a.xml","form_type":"4/A","original_submission_date":"2021-07-02"}},{"id":2435885,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-13T21:08:10.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":536,"price":49.15,"value":26344.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $48.74 to $49.40 per share."}],"balance_after":155849,"source":{"system":"sec-edgar","filing":"0001209191-22-003172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003172/doc4.xml","form_type":"4"}},{"id":2435884,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-13T21:08:10.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":4883,"price":48.46,"value":236630.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through \"sell to cover\" transactions and do not represent discretionary trades by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $47.72 to $48.71 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":156385,"source":{"system":"sec-edgar","filing":"0001209191-22-003172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003172/doc4.xml","form_type":"4"}},{"id":2436737,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-12T21:06:43.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":643,"price":47.15,"value":30317.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $46.97 to $47.42 per share."}],"balance_after":161268,"source":{"system":"sec-edgar","filing":"0001209191-22-003051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003051/doc4.xml","form_type":"4"}},{"id":2436736,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-12T21:06:43.000Z","date":"2022-01-10","kind":"sale","acquired":false,"shares":7095,"price":46.37,"value":328995.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $45.71 to $46.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3."}],"balance_after":161911,"source":{"system":"sec-edgar","filing":"0001209191-22-003051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122003051/doc4.xml","form_type":"4"}},{"id":2448737,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T21:03:21.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested."}],"balance_after":66643,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-000647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122000647/doc4.xml","form_type":"4"}},{"id":2448736,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T21:03:21.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":861,"price":60.31,"value":51926.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $60.30 to $60.33 per share."}],"balance_after":169006,"source":{"system":"sec-edgar","filing":"0001209191-22-000647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122000647/doc4.xml","form_type":"4"}},{"id":2448735,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T21:03:21.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":27812,"price":59.86,"value":1664826.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $59.30 to $60.29 per share."}],"balance_after":169867,"source":{"system":"sec-edgar","filing":"0001209191-22-000647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122000647/doc4.xml","form_type":"4"}},{"id":2448734,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T21:03:21.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":16900,"price":58.84,"value":994396.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $58.26 to $59.25 per share."}],"balance_after":197679,"source":{"system":"sec-edgar","filing":"0001209191-22-000647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122000647/doc4.xml","form_type":"4"}},{"id":2448733,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T21:03:21.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":4427,"price":57.76,"value":255703.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $57.26 to $58.18 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 5."}],"balance_after":214579,"source":{"system":"sec-edgar","filing":"0001209191-22-000647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122000647/doc4.xml","form_type":"4"}},{"id":2448732,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2022-01-04T21:03:21.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":50000,"price":6.55,"value":327500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":219006,"source":{"system":"sec-edgar","filing":"0001209191-22-000647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122000647/doc4.xml","form_type":"4"}},{"id":2500631,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-11-22T22:43:06.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":60958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement."}],"balance_after":169006,"source":{"system":"sec-edgar","filing":"0001209191-21-066163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121066163/doc4.xml","form_type":"4"}},{"id":2551845,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-04T20:12:16.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested."}],"balance_after":116643,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-058930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121058930/doc4.xml","form_type":"4"}},{"id":2551844,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-10-04T20:12:16.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":11844,"price":59.681,"value":706861.764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $59.45 to $60.07 per share."}],"balance_after":108048,"source":{"system":"sec-edgar","filing":"0001209191-21-058930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121058930/doc4.xml","form_type":"4"}},{"id":2551843,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-10-04T20:12:16.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":21844,"price":58.962,"value":1287965.928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $58.45 to $59.44 per share."}],"balance_after":119892,"source":{"system":"sec-edgar","filing":"0001209191-21-058930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121058930/doc4.xml","form_type":"4"}},{"id":2551842,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-10-04T20:12:16.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":16312,"price":58.033,"value":946634.296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $57.41 to $58.36 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 4."}],"balance_after":141736,"source":{"system":"sec-edgar","filing":"0001209191-21-058930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121058930/doc4.xml","form_type":"4"}},{"id":2551841,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-10-04T20:12:16.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":50000,"price":6.55,"value":327500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":158048,"source":{"system":"sec-edgar","filing":"0001209191-21-058930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121058930/doc4.xml","form_type":"4"}},{"id":2644404,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":15383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option is fully vested."}],"balance_after":166643,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":15383},"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644403,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":27685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option is fully vested."}],"balance_after":22315,"derivative":{"exercise_price":4.89,"expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":27685},"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644402,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":6932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option is fully vested."}],"balance_after":27628,"derivative":{"exercise_price":4.84,"expiration_date":"2025-01-05","underlying":"Common Stock","underlying_shares":6932},"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644401,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":5534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.87,"expiration_date":"2023-08-12","underlying":"Common Stock","underlying_shares":5534},"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644400,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":50000,"price":84.56,"value":4228000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":108048,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644399,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":100,"price":95.3,"value":9530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":158048,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644398,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1825,"price":94.6267,"value":172693.7275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price of the shares sold ranging from $94.22 to $95.12 per share."}],"balance_after":158148,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644397,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":400,"price":93.3075,"value":37323.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of the shares sold ranging from $93.21 to $93.54 per share."}],"balance_after":159973,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644396,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":432,"price":92.2585,"value":39855.672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of the shares sold ranging from $91.88 to $92.41 per share."}],"balance_after":160373,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644395,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":225,"price":91.0646,"value":20489.535,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold ranging from $90.81 to $91.64 per share."}],"balance_after":160805,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644394,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":707,"price":90.3016,"value":63843.2312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $89.78 to $90.68 per share."}],"balance_after":161030,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644393,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":400,"price":88.9325,"value":35573.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $88.65 to $89.48 per share."}],"balance_after":161737,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644392,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":1145,"price":87.8953,"value":100640.1185,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $87.50 to $88.28 per share."}],"balance_after":162137,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644391,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":200,"price":86.56,"value":17312.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $86.47 to $86.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 3 through 10."}],"balance_after":163282,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644390,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":100,"price":84.83,"value":8483.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":163482,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644389,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":15383,"price":6.55,"value":100758.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":163582,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644388,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":27685,"price":4.89,"value":135379.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":148199,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644387,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":6932,"price":4.84,"value":33550.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021."}],"balance_after":120514,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2644386,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2021-07-02T23:08:59.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":5534,"price":7.87,"value":43552.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":113582,"source":{"system":"sec-edgar","filing":"0001209191-21-045182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121045182/doc4.xml","form_type":"4"}},{"id":2761040,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option Right to Buy","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":1851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/2 of the shares subject to this option vested in 48 equal monthly installments beginning on November 4, 2013.  The remaining 1/2 of the shares are divided into five equal parts, and 1/5 of such remaining shares vested in 24 equal monthly installments following the Issuer's achievement of one of the five specified performance based milestones."}],"balance_after":10458,"derivative":{"exercise_price":7.87,"expiration_date":"2023-08-12","underlying":"Common Stock","underlying_shares":1851},"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761039,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":28149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares subject to this option vested in 48 equal monthly installments beginning on February 8, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":28149},"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761038,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":400,"price":87.4475,"value":34979.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price of the shares sold ranging from $87.36 to $87.53 per share."}],"balance_after":108048,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761037,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":5299,"price":86.7584,"value":459732.7616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of the shares sold ranging from $86.34 to $87.32 per share."}],"balance_after":108448,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761036,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":4835,"price":85.984,"value":415732.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold ranging from $85.34 to $86.33 per share."}],"balance_after":113747,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761035,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":2200,"price":84.4841,"value":185865.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $84.08 to $84.97 per share."}],"balance_after":118582,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761034,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":3490,"price":83.4041,"value":291080.309,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $83.08 to $84.06 per share."}],"balance_after":120782,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761033,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":4556,"price":82.6853,"value":376714.2268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $82.08 to $83.07 per share."}],"balance_after":124272,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761032,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":8220,"price":81.4758,"value":669731.076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $81.02 to $81.85 per share."}],"balance_after":128828,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761031,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":1000,"price":80.494,"value":80494.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $80.02 to $81.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 9."}],"balance_after":137048,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761030,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":1851,"price":7.87,"value":14567.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":138048,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2761029,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-02T22:03:43.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":28149,"price":2.9,"value":81632.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":136197,"source":{"system":"sec-edgar","filing":"0000899243-21-014635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321014635/doc4.xml","form_type":"4"}},{"id":2899095,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:21:09.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":6851,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 48 equal monthly installments beginning on February 1, 2021 such that this option is fully exercisable on January 1, 2025."}],"balance_after":6851,"derivative":{"exercise_price":109.01,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":6851},"source":{"system":"sec-edgar","filing":"0001209191-21-004955","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004955/doc4.xml","form_type":"4"}},{"id":2899094,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-22T23:21:09.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":18013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vests with respect to the 1/4th of the underlying shares on each of January 8, 2022, January 8, 2023, January 8, 2024, and January 8, 2025."}],"balance_after":108048,"source":{"system":"sec-edgar","filing":"0001209191-21-004955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004955/doc4.xml","form_type":"4"}},{"id":2900591,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T00:08:54.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested."}],"balance_after":28149,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-21-004749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004749/doc4.xml","form_type":"4"}},{"id":2900590,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-22T00:08:54.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":200,"price":117.065,"value":23413.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $117.04 to $117.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":90035,"source":{"system":"sec-edgar","filing":"0001209191-21-004749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004749/doc4.xml","form_type":"4"}},{"id":2900589,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-22T00:08:54.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":4021,"price":115.9743,"value":466332.6603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $115.6382 to $116.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":90235,"source":{"system":"sec-edgar","filing":"0001209191-21-004749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004749/doc4.xml","form_type":"4"}},{"id":2900588,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-22T00:08:54.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":14944,"price":115.092,"value":1719934.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $114.60 to $115.5350 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":94256,"source":{"system":"sec-edgar","filing":"0001209191-21-004749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004749/doc4.xml","form_type":"4"}},{"id":2900587,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-22T00:08:54.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":15835,"price":114.1117,"value":1806958.7695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $113.56 to $114.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":109200,"source":{"system":"sec-edgar","filing":"0001209191-21-004749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004749/doc4.xml","form_type":"4"}},{"id":2900586,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-22T00:08:54.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":35000,"price":2.9,"value":101500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020."}],"balance_after":125035,"source":{"system":"sec-edgar","filing":"0001209191-21-004749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004749/doc4.xml","form_type":"4"}},{"id":2909537,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":872,"price":109.654,"value":95618.288,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.19 to $110.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":90035,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2909536,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1050,"price":110.758,"value":116295.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.19 to $111.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":90907,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2909535,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1332,"price":111.616,"value":148672.512,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.19 to $112.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":91957,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2909534,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":151,"price":114.755,"value":17328.005,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.38 to $115.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":93289,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2909533,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":872,"price":115.799,"value":100976.728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.38 to $116.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":93440,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2909532,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":2451,"price":117.154,"value":287144.454,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.38 to $117.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":94312,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2909531,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2021-01-13T01:39:21.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":2755,"price":117.599,"value":323985.245,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $118.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":96763,"source":{"system":"sec-edgar","filing":"0001209191-21-003339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003339/doc4.xml","form_type":"4"}},{"id":2989632,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-05","kind":"exercise","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested."}],"balance_after":63149,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989631,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-05","kind":"exercise","acquired":false,"shares":9282,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest and become exercisable in 48 monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021."}],"balance_after":25000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":9282},"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989630,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":51519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest and become exercisable in 48 monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021."}],"balance_after":34282,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":51519},"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989629,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":2600,"price":51.1533,"value":132998.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $51.01 to $51.31 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":99518,"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989628,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-05","kind":"sale","acquired":false,"shares":16682,"price":50.5487,"value":843253.4134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":102118,"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989627,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-05","kind":"exercise","acquired":true,"shares":10000,"price":2.9,"value":29000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":118800,"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989626,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-05","kind":"exercise","acquired":true,"shares":9282,"price":2.73,"value":25339.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."}],"balance_after":108800,"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}},{"id":2989625,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":26212,"kind":"person","name":"TAHL CINDY","position":1,"cik":"0001655472","reported_name":"TAHL CINDY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common stock","published_at":"2020-11-06T21:02:43.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":51519,"price":50.4113,"value":2597139.7647,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":99518,"source":{"system":"sec-edgar","filing":"0001209191-20-057265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120057265/doc4.xml","form_type":"4"}}],"next_cursor":"2020-11-06T21:02:43.000000Z,2989625"}